baber/WOPTO huggingface dataset:
Patent NZ-243636-A (NZ)
Title: Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
Inventor: LACROIX MARTIAL
IPC: G01N33/574
Filed: 1992-07-20
Abstract: This invention relates to immunoassay kits which can be used to simultaneously detect antibodies in a biological specimen to the following viruses: HIV-1, HIV-2, HTLV-I and HTLV-II. This invention also relates to the process of making and using these immunoassay kits.
Patent NZ-259281-A (NZ)
Title: Wide band width data path of composite narrow band width channels
Inventor: LONGGINOU LUCAS
IPC: H04N7/08
Filed: 1993-12-17
Abstract: PCT No. PCT/AU93/00673 Sec. 371 Date Oct. 31, 1995 Sec. 102(e) Date Oct. 31, 1995 PCT Filed Dec. 17, 1993 PCT Pub. No. WO94/14273 PCT Pub. Date Jun. 23, 1994An information delivery system comprises equipment located at a first or storage location (10) and additional equipment located at a second or utilization location (11). The locations are interconnected for transmission of information therebetween by a communication medium (12). The system includes elements and methods for increasing the effective rate of transfer of information across information medium 12. These elements and methods include data compression including iterative data compression. The elements and methods further include the synchronised superposition of channels forming communication medium (12). Communication medium (12) can include a cellular mobile telephone network to permit transmission of information between mobile stations (311, 312) and to cellular receivers (217).
Patent NZ-270935-A (NZ)
Title: Reacting polysiloxanes with an alkoxy silane in the presence of fluoride as activator
Inventor: FRIEBE ROBERT
IPC: C08G77/18
Filed: 1995-04-13
Abstract: The novel feature in the reaction of polysiloxanes with alkoxysilanes is that fluoride ions are present as activator, such ions pref. having as their source: (i) an alkali metal fluoride; or (ii) a non-metallic cpd. esp. a tetra-alkylammonium fluoride and/or NH4F as well as trialkylamine-HF and other polyhydrofluorides or tert. org. amines.
Patent NZ-297424-A (NZ)
Title: Use of an aminopurine derivative to treat latent infection of the herpes virus
Inventor: FIELD HUGH JOHN
IPC: A61K/
Filed: 1995-11-23
Abstract: A purine derivative of formula (A) or a bioprecursor or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative thereof is in the preparation of a medicament for the reduction or prevention of herpes virus infection becoming latent and subsequently reactivating in mammals wherein the administration of the medicament commences more than 18 hours post-infection.  The preferred purine derivative is famciclovir and the infection is herpes simplex type 1 or 2.
Patent NZ-328031-A (NZ)
Title: Method of preparing a form (e.g.tablet) from a natually occurring substance includes chilling, comminuting, forming and drying the substance
Inventor: BALLANTYNE ANTHONY
IPC: A61K35/48
Filed: 1997-06-05
Abstract: A method for preparing a form from a naturally occurring substance of biological origin includes the steps of:  i)  chilling the naturally occurring substance until firm;  ii)  comminuting the substance while still firm sufficiently to allow it to be formed in the desired form;  iii)  forming the comminuted substance into the desired form, e.g. a tablet or sheet;  iv)  subsequently drying the formed substance.  The substance may be any one or more of plant based material, plant root material, woody plant material, plant leaf material, herbaceous plant material, fruit, kernels and pips.  The substance may be snap frozen to -5oC or below so it is at least firm to touch, the chilled substance may be comminuted to a size sufficient to pass through 2mm grid apertures.
Patent NZ-330408-A (NZ)
Title: Peptides used to prepare medicaments to stimulate reparative and anabolic processes
Inventor: DEIGIN VLADISLAV ISAAC
IPC: A61K38/07
Filed: 1996-01-31
Abstract: The use in the preparation of a pharmaceutical composition for modulating physiological processes and to stimulate reparative and anabolic process of a peptide of the formula 1  X-Try-Y-Phe-Z-A  X is hydrogen, Arg, ornithine, lysine, homoarginine, cirtulline, tyrosine; Y is D- (ala, val, leu, phenylalanine, asparagine, tryptophan, pro, ser, thr, tyr, hydroxyproline, cys, cysteyl-cysteine, met, lys, homoarginine, arg, his, asp, glutamic acid, beta-ala, ornithine) Phe is phenylalanine Z is ala, val, leu, isoleucine, phe, asp, gly, glu, tryp, pro, ser, thre, tyr, hydroxyproline, cys, cysteyl-cysteine, met, lys, arg, his, aspartic acid, glutamic acid, beta alanine, ornithine A is substituted or unsubstituted OH or amine.
Patent NZ-336574-A (NZ)
Title: Electrochemical cells with double electrode plates including conducting electrode support frame
Inventor: STUART ANDREW T B
IPC: C25B9/20
Filed: 1998-01-02
Abstract: In an electrochemical system, the cells are assembled as a contiguous stack of cells similar in appearance to a filter press. The electrical connections between adjacent cells are made using double electrode plates 110.    In the illustrated embodiment, a mono-polar electrolyser uses double electrode plates where the planar double electrode plates connect cells in adjacent cell stacks.  The mono-polar characteristics of each cell are maintained by the presence of an air gap 28 isolating each adjacent stack of cells connected by each double electrode plate.
Patent NZ-505324-A (NZ)
Title: Liquid and lyophilised KGF-2 polypeptide formulations used to accelerate soft tissue growth or regeneration
Inventor: GENTZ REINER L
IPC: A61P17/02
Filed: 1998-12-22
Abstract: Liquid and lyophilised forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof are described.  Also described is the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing. The pharmaceutical compositions disclosed comprise: (a) KGF-2 polypeptide in a concentration range of about 0.02 to about 40 mg/ml (w/v); (b) a buffer having a buffering capacity of between about pH 5.0 and about pH 8.0 at a concentration range of about 5 mM to about 50 mM; and (c) a pharmaceutically acceptable diluent to bring the composition to a designated volume or a reaction product thereof, and can further comprise (d) a chelating agent at a concentration range of about 0.1 mM to about 10 mM; and (e) NaCI at a concentration range of about 0.01 mM to about 150 mM, and about 0.5% to about 2% w/v glycerol, about 0.1% to about 1% w/v methionine, or  about 0.1% to about 2% w/v monothioglycerol.
Patent NZ-505903-A (NZ)
Title: Beta-carboline compounds (derivatives of harmaline) and composition to treat depression, psychosis, schizophrenia and migraine
Inventor: GOLDSTEIN SOLO
IPC: A61P25/28
Filed: 2000-07-21
Abstract: A process for the preparation of b-carboline related compounds for the formula as shown. The b -carboline related compounds are useful for treating symptoms of depression, psychosis, schizophrenia, phobia, anxiety, panic attacks, sleep disorders, appetite disorders, impulsive and aggressive disorders, sexual disorders, migraine. The compounds are potent selective ligands of 5-HT2 receptors, in particular 5-HT2c and 5HT2B antagonists. Wherein; R1 represents hydrogen, linear or branched C1-6alkyl, -R6-aryl, R6-cycloalkyl, R6-heterocycle, -COOR7, -COOR8, CONH-R8; wherein R6 is a linear or branched C1-6alkylene group, R7 is a linear or branched C1-6alkyl, aryl, cycloalkyl, heterocycle, -R6-cycloalkyl group or -R6-heterocycle, and R8 is hydrogen, a linear or branched C1-6alkyl, aryl, cycloalkyl, heterocycle, -R6-aryl, -R6-cycloalkyl or -R6-heterocycle; R2 represents -CN, -COOR8, -CONHR8, mono-C1-6alkylamino-C1-6alkylaminocarbonyl, di-C1-6alkylamino-C1-6alkylaminocarbonyl, -NR8R9, -NHCOOR7, -COR8 or R3 and R4 together form C3-10cycloalkyl group; R5 represents hydrogen, linear or branched C1-6alkyl group or an aryl-C1-6alkyl group in which the alkyl moiety may be linear or branched; Ra, Rb, Rc and Rd, which may be-identical or different, each represents, independently of the others, a group selected from hydrogen, halogen, linear or branched C1-6alkyl, hydroxy, linear or branched C1-6alkoxy, linear or branched trihalo-C1-6alkyl, linear or branched trihalo-C1-6alkoxy, nitro, cyano, amino, linear or branched C1-6alkylamino, di-C1-6alkylamino in which each alkyl moiety may be linear or branched, aryl, aryl-C1-6alkyl in which the alkyl moiety may be linear or branched, carboxy, linear or branched C1-6alkylcarbonyloxy, linear or branched C1-6acyl, aryloxy, and aryl-C1-6alkoxy in which the alkoxy moiety may be linear or branched.
Patent NZ-509763-A (NZ)
Title: Sigmoidoscope with contamination prevention that does not allow any reuseable part of the sigmoidoscope to be exposed to any contamination from the insufflation medium
Inventor: LUBOWSKI DAVID
IPC: A61B1/313
Filed: 1999-07-30
Abstract: A sigmoidoscope comprising at least one disposable part (1), in combination with means (10) for insufflation of a body cavity with a medium via the sigmoidoscope; said medium being susceptible to contamination by a contaminant (as herein defined) during use of the sigmoidoscope, said insufflation means (10) and said sigmoidoscope (eg part 1) being connected, or adapted for connections one to the other; the sigmoidoscope and/or the insufflation means being provided with disposable contamination prevention means (18), or being so formed and arranged, that no non-disposable part of the sigmoidoscope (eg 15) and no non-disposable part of the insufflation means is exposed to any contaminated medium during use of the sigmoidoscope.
Patent NZ-514914-A (NZ)
Title: Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
Inventor: CURD JOHN G
IPC: A61K47/48
Filed: 2000-05-04
Abstract: Disclosed is the use of antibodies that bind CD20 in the preparation of a medicament that treats non-malignant or non-cancerous diseases or disorders in a mammal. Such diseases or disorders include inflammatory responses such as inflammatory skin diseases including psoriasis and dermatitis (e. g. atopic dermatitis); systemic scleroderma and sclerosis; responses associated with inflammatory bowel disease (such as Crohn's disease and ulcerative colitis); respiratory distress syndrome (including adult respiratory distress syndrome; ARDS); dermatitis ; meningitis ; encephalitis; uveitis ; colitis ; glomerulonephritis ; allergic conditions such as eczema and asthma and other conditions involving infiltration of T cells and chronic inflammatory responses ; atherosclerosis ; leukocyte adhesion deficiency ; rheumatoid arthritis ; systemic lupus erythematosus (SLE) ; diabetes mellitus (e. g. Type I diabetes mellitus or insulin dependent diabetes mellitis); multiple sclerosis ; Reynaud's syndrome ; autoimmune thyroiditis ; allergic encephalomyelitis ; Sjorgen's syndrome ; juvenile onset diabetes ; and immune responses associated with acute and delayed hypersensitivity mediated by cytokines and T-lymphocytes typically found in tuberculosis , sarcoidosis , polymyositis , granulomatosis and vasculitis ; pernicious anemia (Addison's disease ); diseases involving leukocyte diapedesis ; central nervous system (CNS) inflammatory disorder; multiple organ injury syndrome ; hemolytic anemia (including, but not limited to cryoglobinemia or Coombs positive anemia ); myasthenia gravis ; antigen-antibody complex mediated diseases; anti-glomerular basement membrane disease ; antiphospholipid syndrome ; allergic neuritis ; Graves' disease ; Lambert-Eaton myasthenic syndrome; pemphigoid bullous ; pemphigus ; autoimmune polyendocrinopathies ; Reiter's disease ; stiff-man syndrome ; Behcet disease ; giant cell arteritis ; immune complex nephritis ; IgA nephropathy ; IgM polyneuropathies ; immune thrombocytopenic purpura (ITP) and autoimmune thrombocytopenia . Particular antibodies useful for treating such diseases include chimeric and humanized antibodies, antibodies conjugated with cytotoxic agents and more specifically include rituximab and Y2B8 or 131I-B1.
Patent NZ-516450-A (NZ)
Title: Data visualisation system using contours and lines to show data relationships
Inventor: CARDNO ANDREW JOHN
IPC: G06F17/30
Filed: 2000-06-14
Abstract: A data visualisation system comprises: a data value memory in which is maintained a finite set of data values; a display arranged to display a representation of each data value centred on respective data points; and a contour generator arranged to generate a contoured representation around each data point such that each data point is displayed as a local maximum. The data visualisation system, further comprises: a memory in which is maintained an interaction database of interaction data representing interactions between customers and merchants; and a retrieval device arranged to retrieve from the interaction database data representing interactions between customers and merchants, to construct the finite set of data values from the retrieved data and to store the data values in the data value memory.
Patent NZ-517949-A (NZ)
Title: Synergistic combinations of an NK1 receptor antagonist and a GABA structural analog
Inventor: HUGHES JOHN
IPC: A61K45/00
Filed: 2000-10-05
Abstract: A synergistic combination for preventing and treating chronic pain, comprising a Neurokinin-1 (NK1) receptor antagonist and a ã-aminobutyric acid (GABA) analog.  Also covered are pharmaceutical compositions containing said combination.
Patent NZ-522503-A (NZ)
Title: Synthetic method for the fluoromethylation of alcohols
Inventor: BIENIARZ CHRISTOPHER
IPC: C07C41/50
Filed: 2001-05-30
Abstract: A method for fluoromethylating halogenated alcohols, comprising the steps of: (a) reacting a halogenated alcohol with a dialkoxymethane of formula CH2(OR)2 to form an acetal compound, wherein R is alkyl, alkenyl or alkynyl, (b) chlorinating the acetal compound with a chlorinating agent to form a chloromethyl ether, and (c) fluorinating the chloromethyl ether to a fluoride with a fluorinating agent to form a fluorinated haloalcohol.
Patent NZ-523174-A (NZ)
Title: New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them
Inventor: GUO ZONGRU
IPC: A61P25/16
Filed: 2001-06-27
Abstract: Compounds of formula (I) that are suitable for treating epilepsy are disclosed: wherein R1 represents a linear or branched (C1-C12) alkyl or a ureido group, R2 represents hydrogen or a linear or branched (C1-C12) alkyl, or R1 and R2 together with the carbon atom carrying them form a 5- or 6-membered cycloalkyl ring, R3 represents a group CN, NO2, NRaR'a, NRaSO2, NR'aCZR5 or CZNRaR'a, R4 represents a hydrogen atom or a group R3.
Patent NZ-524392-A (NZ)
Title: Pool and spa filter media
Inventor: COX STEPHEN T
IPC: B01D39/16
Filed: 2001-06-05
Abstract: Disclosed is an antimicrobial nonwoven filter media, comprising an antimicrobial fiber, a second fiber and a binder, wherein the antimicrobial fiber and second fiber are entangled together.
Patent NZ-530881-A (NZ)
Title: Method for producing clean energy from coal
Inventor: CALDERON ALBERT
IPC: C10J3/00
Filed: 2002-07-08
Abstract: A method for producing clean energy from coal by feeding the coal in a reactor which is sealed to the atmosphere and moving the coal in the reactor while injecting oxygen to combust a portion of the coal in a substoichiometric mode to devolatilize the coal and yield a pressurized hydrogen rich raw gas which contains coal-derived cancer causing distillates and hydrocarbons together with a hot char. The distillates and the hydrocarbons are cracked to result in a cracked gas of essentially 2H2 and 1CO which after desulfurization becomes an ideal synthesis gas that can be synthesized to a liquid fuel for heating and transportation as an alternate to petroleum. The hot char is gasified in an air blown gasifier to produce a fuel gas and a molten slag which are jointly directed out of the gasifier through a common port which is maintained open for the free flow of both. The fuel gas and the molten slag separate from each other by flowing both gas and slag through a molten bath in a submerged manner in order to effectively scrub the fuel gas in the molten bath while it bubbles out of the bath. After separation the fuel gas is treated for sulfur removal and is in condition for use as an efficient gas turbine fuel for power generation by virtue of its mass, while producing very low NOx emissions when combusted. This fuel gas can also be used for raising steam and for clean burning in industrial heating. The method is capable of making coke and/or activated carbon.
Patent NZ-531069-A (NZ)
Title: Methods for modulating viral infection of cells by modulating a binding interaction between a CCR1, CCR2, CCR3, CCR4, CCR5 and/or CCR8 receptor and a surface protein of the virus
Inventor: RENZI PAOLO
IPC: C07K16/28
Filed: 2002-08-12
Abstract: A method of modulating viral infection of a cell comprising modulating a binding interaction between a cell chemokine-receptor selected from the group consisting of CCR1, CCR2, CCR3, CCR4, CCR5 and/or a CCR8 receptor and a surface protein of a virus. The cell chemokine-receptor comprises an amino acid sequence having at least 70% identity with SEQ ID NO:6.
Patent NZ-532603-A (NZ)
Title: Suction sequences for a breastpump
Inventor: SILVER BRIAN H
IPC: A61M1/06
Filed: 2000-12-07
Abstract: A method for operating a breast pump comprising varying the amount of vacuum within a range of from about 20mmhg (the least vacuum) to about 250mmhg while simultaneously varying the overall suction cycle from about 25 cycles/min at the greatest vacuum to about 40 cycles/min at the least vacuum, such that for a lower vacuum applied there is an increase in the number of cycles. (62) Divided out of 519421
Patent NZ-534476-A (NZ)
Title: Personal device fastening system
Inventor: JOHNSON PHILLIP LEE
IPC: A45C13/20
Filed: 2003-01-22
Abstract: The invention relates to a clip (300) for capturing at least one capture member (401) within a capture zone (311). A gate (320) blocks an opening (310a) of the capture zone to thereby capture the capture member(s). The clip may be attached to a person by way of an attachment member (350), such as an attachment hook. A personal device such as a mobile phone (10) may be secured to the clip via a capture member locatable within the capture zone. Accordingly, the personal device is attachable to the person via the clip when worn by the person. The invention also relates to a clasp (500) that is capable of capturing a detention member (403) within a detention zone (530).
Patent NZ-537019-A (NZ)
Title: Extensible object previewer data structure
Inventor: KURTZ JAMES BRIAN
Filed: 2003-04-01
Abstract: One or more computer-readable media having stored thereon a data structure is disclosed. The data structure comprises: a first field containing information indicative of a default previewer in a shell browser which supports multiple item types; a second field containing information indicative of an alternative previewer for a first item type; and a third field containing information indicative of whether to invoke the default previewer or the alternative previewer when one or more items of the first item type are displayed in the shell browser.
Patent NZ-543459-A (NZ)
Inventor: GIACHERI MARK
IPC: A63B71/12
Filed: 2004-04-22
Abstract: A grippable sports device (201) in the form of a band is configured for use as a lifting aid and comprises a main body (202) for placing in a position on the limb of a sports player for use during a sports game, said main body comprising fixing means for fixing said main body in a substantially fixed position directly on said limb of said player and said main body further comprising grip means (203) comprising a non-slip surface specifically configured to enable a second player of said sports game to firmly grip said main body, said sports device characterised in that: when said sports band is in said fixed position, said fixing means substantially encircles a portion of said limb, said fixing means substantially comprising an elasticated material for effecting said fixing by virtue of the elastic tension provided by said elastic material. The grippable sports band is particularly useful in aiding raising of a player in a line-out in the game of Rugby Union.
Patent NZ-555281-A (NZ)
Title: 2-methylene-19,26,27-trinor-(20s)-1alpha-alpha-hydroxyvitamin D3 and its uses
Inventor: DELUCA HECTOR F
IPC: A61K31/59
Filed: 2005-11-18
Abstract: Provided is the compound 2-methylene-19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and related compounds which are useful to treat psoriasis, leukemia, cancer, multiple sclerosis and other diseases.
Patent NZ-555414-A (NZ)
Title: Composite panel with flanged forms embedded in a settable material
Inventor: CLIFTON GEORGE CHARLES
Filed: 2007-05-25
Abstract: A composite panel with complementary reinforcing forms embedded in a settable material is disclosed. A first form (1) has a part (14) which extends from a region near a first side of the panel to a flange (8, 9) embedded within the panel nearer to a second side of the panel. A complementary second form has a part which extends from a region near the second side of the panel to a flange embedded nearer to the first side. There may be a set of first and/or second forms. The flanges of the first and second forms have parallel longitudinal axes. The flanges interact via the settable material to confer a structural or load bearing advantage to the panel.
Patent NZ-583291-A (NZ)
Title: Malaria prime/boost vaccines using adenoviral vectors and adjuvated proteins
Inventor: HEPPNER DONALD G
IPC: A61K39/015
Filed: 2005-10-13
Abstract: Disclosed is the use of a replication-defective recombinant adenovirus comprising a heterologous nucleic acid encoding a CS antigen from a malaria-causing parasite, and an adjuvated proteinaceous antigen selected from a CS protein or an immunogenic fragment thereof comprising a C-terminal portion of the CS protein, four or more tandem repeats of the immunodominant region, and the surface antigen from hepatitis B virus, wherein said proteinaceous antigen is adjuvated with an adjuvant comprising QS21 and 3D-MPL in the manufacture of a medicament for the treatment or prevention of malaria, wherein said recombinant adenovirus is a simian, a canine, a bovine adenovirus or a human adenovirus serotype 11, 24, 26, 34, 35, 48, 49 or 50.
Patent NZ-585926-A (NZ)
Title: Methods for generating marker free transgenic plants using Agrobacterium strains and virE2 protein
Inventor: BRUGGEMAN ILONA MARGARETHA
IPC: C12N15/82
Filed: 2008-12-05
Abstract: Disclosed is a method of creating marker free transgenic plants using two Agrobacterium strains. The virE2 expression is blocked by the modification of the tms and tmr regions of T-DNA so that no functional virE2 protein can be made.
Patent NZ-586203-A (NZ)
Title: Process and compounds for the production of (+) opiates
Inventor: WANG PETER X
IPC: C07D221/22
Filed: 2008-12-17
Abstract: Disclosed herein are compounds of formula (Ib) processes and intermediate compounds useful for the production of (+)-opiates, wherein the variables shown in formula (Ib) are as defined in the specification. Non-limiting examples of (+) opiates that may be derived from one or more of these compounds include Nordihydrosinome-nine t, (+ )-norhydrocodone and (+)-norhydromorphone. The compounds described herein may have a (-) or (+) stereochemistry configuration, with respect to the rotation of polarized light. More specifically, each chiral center may have an R or an S configuration.